N2O/O2 (Linde Gas Therapeutics, AGA, Kolding, Denmark) was administered using an Analgisor® (Drager S&W,

Denmark) with double mask and a scavenging system according to the KU-60019 in vitro following recommended scheme[11]: An induction phase of 5 min of pure O2. Five minutes with increasing concentration of N2O. Five minutes with at concentration of 50% N2O and 50% O2. Five minutes of pure O2. The mask was removed. Atmospheric air (Linde Gas Therapeutics, AGA, Kolding, Denmark) was used as a placebo. The children were carefully monitored for oversedation. Both the dentist and the chair-side dental assistant had extensive experience in the use of N2O/O2. Each test session took approximately 55 min. The analysis was based on the average of the three replicates of each measurement of each test. The difference between the average measurement in session 2 and the corresponding average in session 1 was computed for each test. For ABT-199 ic50 each measurement in each test, the unadjusted (crude) effect of the NO2/O2 was assessed by comparing the differences in Group A with the differences in Group B using a t-test. The crude effect of NO2/O2 was estimated as half the difference between the average difference in Group A and the average difference in Group B[12].

Analysis of covariance was used to assess the NO2/O2 effect on tooth-pulp pain sensitivity and on muscle pressure pain threshold adjusted for the effect of NO2/O2 on reaction time. The study was approved by The Central Denmark Region Committees on Biomedical Research Ethics (Record # M-20070261), Danish Medicines Agency (record # 2012014352; EudraCT Number: 2009-009917-16); The Danish Data protection Agency (Record # 2009-41-3521). GCP-unit, Aarhus University Hospital, Aarhus, Denmark (record # 2008/275), and registered in ClinicalTrials.gov (record # NCT01022294). A total of 78 children participated in the information meetings. Of these, 20 children withdrew from the study before the initiation of

the study for various reasons: two had left the school; four disliked the effect of N2O/O2; two had had a traumatic injury to both upper central incisors; for one child, the consent was eventually withdrawn by the mother; for one child, consent could for practical reasons not Reverse transcriptase be obtained from the father; one child continued to break the appointment for the information meeting; one had left for vacation; one had orthodontic appliances; one was very nervous; and six eventually refused to participate. Of these, two children could not complete the study due to a feeling of unpleasant dizziness, resulting in a total of 56 children completing the entire trial. More than half of the 56 children, who completed the study, were 12 years of age, and almost 60% were boys (Table 1). Three (5.4%) children had a non-Danish ethnic background, and 22 (39.3%) had previous experience with N2O/O2 inhalation sedation. In 51 (91.